Edwards Lifesciences Corp (NYSE:EW)
| 68.34 Delayed Data As of 4:00pm ET |  +0.63 / +0.93%Today’s Change | 60.57 Today|||52-Week Range 94.87 | -8.40% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $41.2B |
Company Description
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Contact Information
Edwards Lifesciences Corp. 1 Edwards Way Irvine California 92614 |
Employees
Shareholders
| Mutual fund holders | 49.24% |
| Other institutional | 36.04% |
| Individual stakeholders | 1.16% |
Top Executives
| Bernard J. Zovighian | President, Chief Executive Officer & Director |
| Scott B. Ullem | Chief Financial Officer & Vice President |
| Todd J. Brinton | Chief Scientific Officer & VP-Advanced Technology |
| Linda J. Park | Secretary, Senior VP & Associate General Counsel |
| Larry L. Wood | Vice President |
